Danaher ROE 2010-2025 | DHR

Current and historical return on equity (ROE) values for Danaher (DHR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Danaher ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $3.77B $50.86B 7.47%
2024-12-31 $3.90B $49.55B 7.64%
2024-09-30 $3.89B $51.31B 7.48%
2024-06-30 $4.20B $49.90B 8.03%
2024-03-31 $4.40B $53.45B 8.34%
2023-12-31 $4.74B $53.49B 9.07%
2023-09-30 $5.87B $52.42B 11.42%
2023-06-30 $6.30B $51.72B 12.57%
2023-03-31 $6.85B $51.49B 14.03%
2022-12-31 $7.10B $50.09B 14.95%
2022-09-30 $6.64B $46.99B 14.35%
2022-06-30 $6.21B $46.60B 13.67%
2022-03-31 $6.29B $46.36B 14.16%
2021-12-31 $6.27B $45.18B 14.59%
2021-09-30 $5.72B $43.46B 13.75%
2021-06-30 $5.45B $42.77B 13.54%
2021-03-31 $4.60B $40.43B 11.90%
2020-12-31 $3.51B $39.78B 9.68%
2020-09-30 $3.57B $37.97B 10.52%
2020-06-30 $3.37B $36.27B 10.31%
2020-03-31 $3.19B $31.07B 10.06%
2019-12-31 $2.94B $30.28B 9.24%
2019-09-30 $2.43B $33.20B 7.77%
2019-06-30 $2.45B $32.21B 8.18%
2019-03-31 $2.41B $31.57B 8.41%
2018-12-31 $2.65B $28.23B 9.61%
2018-09-30 $2.76B $27.69B 10.18%
2018-06-30 $2.67B $27.22B 10.06%
2018-03-31 $2.55B $27.20B 9.86%
2017-12-31 $2.49B $26.37B 9.95%
2017-09-30 $2.38B $25.38B 9.84%
2017-06-30 $2.20B $24.60B 9.30%
2017-03-31 $2.30B $23.79B 9.67%
2016-12-31 $2.55B $23.08B 10.64%
2016-09-30 $2.50B $23.26B 10.32%
2016-06-30 $3.51B $25.12B 14.51%
2016-03-31 $3.55B $24.58B 14.82%
2015-12-31 $3.36B $23.76B 14.21%
2015-09-30 $3.33B $23.18B 14.14%
2015-06-30 $2.61B $24.17B 11.01%
2015-03-31 $2.59B $23.39B 10.97%
2014-12-31 $2.60B $23.45B 11.05%
2014-09-30 $2.73B $23.81B 11.71%
2014-06-30 $2.64B $23.79B 11.66%
2014-03-31 $2.58B $23.03B 11.85%
2013-12-31 $2.70B $22.45B 12.84%
2013-09-30 $2.54B $21.37B 12.59%
2013-06-30 $2.49B $20.37B 12.73%
2013-03-31 $2.47B $19.75B 12.98%
2012-12-31 $2.39B $19.08B 12.88%
2012-09-30 $2.33B $18.95B 12.93%
2012-06-30 $2.31B $18.37B 13.22%
2012-03-31 $2.36B $17.89B 13.86%
2011-12-31 $2.17B $16.97B 13.40%
2011-09-30 $2.08B $16.56B 13.47%
2011-06-30 $2.20B $16.56B 15.10%
2011-03-31 $1.92B $14.72B 14.30%
2010-12-31 $1.79B $13.77B 14.09%
2010-09-30 $1.59B $13.17B 13.02%
2010-06-30 $1.29B $12.06B 11.04%
2010-03-31 $1.21B $11.85B 10.72%
2009-12-31 $1.15B $11.63B 10.61%
Sector Industry Market Cap Revenue
Medical Medical Services $138.024B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $80.885B 10.05
Elevance Health (ELV) United States $75.961B 9.80
Cencora (COR) United States $57.110B 19.87
DiDi Global (DIDIY) China $25.792B 27.40
Labcorp Holdings (LH) United States $20.561B 16.68
Natera (NTRA) United States $20.462B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.598B 0.00
CochLear (CHEOY) Australia $12.760B 0.00
Solventum (SOLV) United States $12.748B 13.49
ICON (ICLR) Ireland $11.757B 10.93
Revvity (RVTY) United States $11.304B 19.45
Viatris (VTRS) United States $10.481B 3.60
Medpace Holdings (MEDP) United States $8.988B 23.87
Sonic Healthcare (SKHHY) Australia $8.788B 0.00
Avantor (AVTR) United States $8.736B 12.69
HealthEquity (HQY) United States $8.317B 36.43
Charles River Laboratories (CRL) United States $7.584B 14.86
Caris Life Sciences,�Inc (CAI) United States $7.355B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.851B 28.56
BrightSpring Health Services (BTSG) United States $3.527B 32.35
Sotera Health (SHC) United States $3.230B 18.35
Surgery Partners (SGRY) United States $2.799B 36.40
Alignment Healthcare (ALHC) United States $2.623B 0.00
Concentras Parent (CON) United States $2.543B 14.70
Organon (OGN) United States $2.485B 2.64
GeneDx Holdings (WGS) United States $2.331B 89.77
Progyny (PGNY) United States $1.992B 43.85
Ardent Health (ARDT) United States $1.991B 8.49
PACS (PACS) United States $1.897B 0.00
Premier (PINC) United States $1.719B 13.05
GoodRx Holdings (GDRX) United States $1.697B 33.93
Teladoc Health (TDOC) United States $1.388B 0.00
Establishment Labs Holdings (ESTA) $1.285B 0.00
Pediatrix Medical (MD) United States $1.100B 8.37
CareDx (CDNA) United States $1.058B 16.53
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.911B 0.00
QDM (QDMI) Hong Kong, SAR China $0.848B 291.00
AMN Healthcare Services Inc (AMN) United States $0.761B 7.13
Nutex Health (NUTX) United States $0.632B 9.57
InnovAge Holding (INNV) United States $0.564B 0.00
Embecta (EMBC) United States $0.560B 3.77
SBC Medicals (SBC) United States $0.511B 0.00
LifeMD (LFMD) United States $0.497B 0.00
Sonida Senior Living (SNDA) United States $0.473B 0.00
Auna S.A (AUNA) Luxembourg $0.472B 10.63
Omada Health (OMDA) $0.463B 0.00
So-Young (SY) China $0.455B 0.00
Enhabit (EHAB) United States $0.354B 29.17
COMPASS Pathways (CMPS) United Kingdom $0.333B 0.00
Performant Healthcare (PHLT) United States $0.309B 0.00
Oncology Institute (TOI) United States $0.265B 0.00
Beauty Health (SKIN) United States $0.207B 0.00
DocGo (DCGO) United States $0.142B 23.17
Pheton Holdings (PTHL) China $0.136B 0.00
Sera Prognostics (SERA) United States $0.102B 0.00
Ascend Wellness Holdings (AAWH) United States $0.072B 0.00
KindlyMD (NAKA) United States $0.071B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Basel Medical Group (BMGL) Singapore $0.047B 0.00
Biodesix (BDSX) United States $0.045B 0.00
ModivCare (MODV) United States $0.045B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
SeaStar Medical Holding (ICU) United States $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00